Erratum to "The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism", [Neurobiol. Aging, 36, (2015), 1221.e1-1221.e6], doi:10.1016/j.neurobiolaging.2014.08.024.;The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 1221.e1-1221.e6

  Schottlaender, Lucia V ^a   Polke, James M ^a   Ling, Helen ^a   MacDoanld, Nicola D ^a   Tucci, Arianna ^a   Nanji, Tina ^a   Pittman, Alan ^a   de Silva, Rohan ^a   Holton, Janice L ^a   Revesz, Tamas ^a   Sweeney, Mary G ^a   Singleton, Andy B ^b   Lees, Andrew J ^a   Bhatia, Kailash P ^a   Houlden, Henry ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

C9orf72; Corticobasal degeneration (CBD) and corticobasal syndrome (CBS); Multiple system atrophy (MSA); Parkinsonism; Progressive supranuclear palsy (PSP)

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DISEASE; C9ORF72 GENE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOBASAL SYNDROME; DISEASE ASSOCIATION; DNA STRUCTURE; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; GGGGCC REPEAT EXPANSION; HUMAN; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEUROPATHOLOGY; PARKINSONISM; PEDIGREE ANALYSIS; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SOUTHERN BLOTTING; BASAL GANGLION; DEGENERATIVE DISEASE; EXTRAPYRAMIDAL SYNDROME; GENETICS; PATHOLOGY; SYNDROME;

C9ORF72 PROTEIN, HUMAN; PROTEIN; REPETITIVE DNA;

ADULT; AGED; BASAL GANGLIA; BASAL GANGLIA DISEASES; DNA REPEAT EXPANSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURODEGENERATIVE DISEASES; PARKINSONIAN DISORDERS; PROTEINS; SUPRANUCLEAR PALSY, PROGRESSIVE; SYNDROME;

EID: 84922868212     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.02.027     Document Type: Erratum

References (52)

1. Ahmed Z., Asi Y.T., Sailer A., Lees A.J., Houlden H., Revesz T., Holton J.L. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol. Appl. Neurobiol. 2012, 38:4-24.
2. Al-Chalabi A., Dürr A., Wood N.W., Parkinson M.H., Camuzat A., Hulot J.-S., Morrison K.E., Renton A., Sussmuth S.D., Landwehrmeyer B.G., Ludolph A., Agid Y., Brice A., Leigh P.N., Bensimon G. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 2009, 4:e7114. NNIPPS Genetic Study Group.
3. Armstrong M.J., Litvan I., Lang A.E., Bak T.H., Bhatia K.P., Borroni B., Boxer A.L., Dickson D.W., Grossman M., Hallett M., Josephs K.A., Kertesz A., Lee S.E., Miller B.L., Reich S.G., Riley D.E., Tolosa E., Tröster A.I., Vidailhet M., Weiner W.J. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013, 80:496-503.
4. Beck J., Poulter M., Hensman D., Rohrer J.D., Mahoney C.J., Adamson G., Campbell T., Uphill J., Borg A., Fratta P., Orrell R.W., Malaspina A., Rowe J., Brown J., Hodges J., Sidle K., Polke J.M., Houlden H., Schott J.M., Fox N.C., Rossor M.N., Tabrizi S.J., Isaacs A.M., Hardy J., Warren J.D., Collinge J., Mead S. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am. J. Hum. Genet. 2013, 92:345-353.
5. Benussi L., Ghidoni R., Pegoiani E., Moretti D.V., Zanetti O., Binetti G. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol. Dis. 2009, 33:379-385.
6. Bieniek K.F., Murray M.E., Rutherford N.J., Castanedes-Casey M., DeJesus-Hernandez M., Liesinger A.M., Baker M.C., Boylan K.B., Rademakers R., Dickson D.W. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion. Acta Neuropathol. 2013, 125:289-302.
7. Byrne S., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., Heverin M., Jordan N., Kenna K., Lynch C., McLaughlin R.L., Iyer P.M., O'Brien C., Phukan J., Wynne B., Bokde A.L., Bradley D.G., Pender N., Al-Chalabi A., Hardiman O. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012, 11:232-240.
8. Byrne S., Heverin M., Elamin M., Bede P., Lynch C., Kenna K., MacLaughlin R., Walsh C., Al Chalabi A., Hardiman O. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2013, 74:699-708.
9. Cooper-Knock J., Frolov A., Highley J.R., Charlesworth G., Kirby J., Milano A., Hartley J., Ince P.G., McDermott C.J., Lashley T., Revesz T., Shaw P.J., Wood N.W., Bandmann O. C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study. Neurology 2013, 81:808-811.
10. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.-Y.R., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
11. Dejesus-Hernandez M., Rayaprolu S., Soto-Ortolaza A.I., Rutherford N.J., Heckman M.G., Traynor S., Strongosky A., Graff-Radford N., Van Gerpen J., Uitti R.J., Shih J.J., Lin S.C., Wszolek Z.K., Rademakers R., Ross O.A. Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndrome. Parkinsonism Relat. Disord. 2013, 19:198-201.
12. Dopper E.G.P., Seelaar H., Chiu W.Z., de Koning I., van Minkelen R., Baker M.C., Rozemuller A.J.M., Rademakers R., van Swieten J.C. Symmetrical corticobasal syndrome caused by a novel C.314dup progranulin mutation. J.Mol. Neurosci. 2011, 45:354-358.
13. Fallis B.A., Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds. Amyotroph. Lateral Scler. 2009, 10:95-98.
14. Ferrari R., Mok K., Moreno J.H., Cosentino S., Goldman J., Pietrini P., Mayeux R., Tierney M.C., Kapogiannis D., Jicha G.A., Murrell J.R., Ghetti B., Wassermann E.M., Grafman J., Hardy J., Huey E.D., Momeni P. Screening for C9ORF72 repeat expansion in FTLD. Neurobiol. Aging 2012, 33:1850.e1-1850.e11.
15. Fratta P., Poulter M., Lashley T., Rohrer J.D., Polke J.M., Beck J., Ryan N., Hensman D., Mizielinska S., Waite A.J., Lai M.-C., Gendron T.F., Petrucelli L., Fisher E.M.C., Revesz T., Warren J.D., Collinge J., Isaacs A.M., Mead S. Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta Neuropathol. 2013, 126:401-409.
16. Galimberti D., Arosio B., Fenoglio C., Serpente M., Cioffi S.M.G., Bonsi R., Rossi P., Abbate C., Mari D., Scarpini E. Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions: frequency in a cohort of geriatric non-demented subjects. J.Alzheimers Dis. 2014, 39:19-22.
17. Gijselinck I., Van Langenhove T., van der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., Engelborghs S., Sieben A., De Jonghe P., Vandenberghe R., Santens P., De Bleecker J., Maes G., Bäumer V., Dillen L., Joris G., Cuijt I., Corsmit E., Elinck E., Van Dongen J., Vermeulen S., Van den Broeck M., Vaerenberg C., Mattheijssens M., Peeters K., Robberecht W., Cras P., Martin J.-J., De Deyn P.P., Cruts M., Van Broeckhoven C. AC9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 2012, 11:54-65.
18. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., Wood N.W., Colosimo C., Dürr A., Fowler C.J., Kaufmann H., Klockgether T., Lees A., Poewe W., Quinn N., Revesz T., Robertson D., Sandroni P., Seppi K., Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
19. Gómez-Tortosa E., Gallego J., Guerrero-López R., Marcos A., Gil-Neciga E., Sainz M.J., Díaz A., Franco-Macías E., Trujillo-Tiebas M.J., Ayuso C., Pérez-Pérez J. C9ORF72 hexanucleotide expansions of 20-22 repeats are associated with frontotemporal deterioration. Neurology 2013, 80:366-370.
20. Harms M., Benitez B.A., Cairns N., Cooper B., Cooper P., Mayo K., Carrell D., Faber K., Williamson J., Bird T., Diaz-Arrastia R., Foroud T.M., Boeve B.F., Graff-Radford N.R., Mayeux R., Chakraverty S., Goate A.M., Cruchaga C. C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA Neurol. 2013, 70:736-741. NIA-LOAD/NCRAD Family Study Consortium.
21. Höglinger G.U., Melhem N.M., Dickson D.W., Sleiman P.M.A., Wang L.-S., Klei L., Rademakers R., de Silva R., Litvan I., Riley D.E., van Swieten J.C., Heutink P., Wszolek Z.K., Uitti R.J., Vandrovcova J., Hurtig H.I., Gross R.G., Maetzler W., Goldwurm S., Tolosa E., Borroni B., Pastor P., Cantwell L.B., Han M.R., Dillman A., van der Brug M.P., Gibbs J.R., Cookson M.R., Hernandez D.G., Singleton A.B., Farrer M.J., Yu C.-E., Golbe L.I., Revesz T., Hardy J., Lees A.J., Devlin B., Hakonarson H., Müller U., Schellenberg G.D. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet. 2011, 43:699-705. PSP Genetics Study Group.
22. Houlden H., Baker M., Morris H.R., MacDonald N., Pickering-Brown S., Adamson J., Lees A.J., Rossor M.N., Quinn N.P., Kertesz A., Khan M.N., Hardy J., Lantos P.L., St George-Hyslop P., Munoz D.G., Mann D., Lang A.E., Bergeron C., Bigio E.H., Litvan I., Bhatia K.P., Dickson D., Wood N.W., Hutton M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001, 56:1702-1706.
23. Jeon B.S., Farrer M.J., Bortnick S.F. Mutant COQ2 in multiple-system atrophy. N.Engl. J. Med. 2014, 371:80. Korean Canadian Alliance on Parkinson's Disease and Related Disorders.
24. Kara E., Ling H., Pittman A.M., Shaw K., de Silva R., Simone R., Holton J.L., Warren J.D., Rohrer J.D., Xiromerisiou G., Lees A., Hardy J., Houlden H., Revesz T. The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobiol. Aging 2012, 33:2231.e7-2231.e14.
25. Kiely A.P., Asi Y.T., Kara E., Limousin P., Ling H., Lewis P., Proukakis C., Quinn N., Lees A.J., Hardy J., Revesz T., Houlden H., Holton J.L. α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?. Acta Neuropathol. 2013, 125:753-769.
26. King A., Al-Sarraj S., Troakes C., Smith B.N., Maekawa S., Iovino M., Spillantini M.G., Shaw C.E. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant. Acta Neuropathol. 2013, 125:303-310.
27. Kouri N., Carlomagno Y., Baker M., Liesinger A.M., Caselli R.J., Wszolek Z.K., Petrucelli L., Boeve B.F., Parisi J.E., Josephs K.A., Uitti R.J., Ross O.A., Graff-Radford N.R., DeTure M.A., Dickson D.W., Rademakers R. Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol. (Berl.) 2014, 127:271-282.
28. Kouri N., Whitwell J.L., Josephs K.A., Rademakers R., Dickson D.W. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat. Rev. Neurol. 2011, 7:263-272.
29. Lesage S., Le Ber I., Condroyer C., Broussolle E., Gabelle A., Thobois S., Pasquier F., Mondon K., Dion P.A., Rochefort D., Rouleau G.A., Dürr A., Brice A. C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain 2013, 136:385-391. French Parkinson's Disease Genetics Study Group.
30. Lindquist S.G., Duno M., Batbayli M., Puschmann A., Braendgaard H., Mardosiene S., Svenstrup K., Pinborg L.H., Vestergaard K., Hjermind L.E., Stokholm J., Andersen B.B., Johannsen P., Nielsen J.E. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin. Genet. 2013, 83:279-283.
31. Ling H., de Silva R., Massey L.A., Courtney R., Hondhamuni G., Bajaj N., Lowe J., Holton J.L., Lees A., Revesz T. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol. Appl. Neurobiol. 2014, 40:149-163.
32. Ling H., O'Sullivan S.S., Holton J.L., Revesz T., Massey L.A., Williams D.R., Paviour D.C., Lees A.J. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 2010, 133:2045-2057.
33. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., Goetz C.G., Golbe L.I., Grafman J., Growdon J.H., Hallett M., Jankovic J., Quinn N.P., Tolosa E., Zee D.S. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
34. Majounie E., Abramzon Y., Renton A.E., Perry R., Bassett S.S., Pletnikova O., Troncoso J.C., Hardy J., Singleton A.B., Traynor B.J. Repeat expansion in C9ORF72 in Alzheimer's disease. N.Engl. J. Med. 2012, 366:283-284.
35. Mignarri A., Battistini S., Tomai Pitinca M.L., Monti L., Burroni L., Ginanneschi F., Ricci C., Bavazzano A., Federico A., Restagno G., Dotti M.T. Double trouble? Progranulin mutation and C9ORF72 repeat expansion in a case of primary non-fluent aphasia. J.Neurol. Sci. 2014, 341:176-178.
36. Mok K., Traynor B.J., Schymick J., Tienari P.J., Laaksovirta H., Peuralinna T., Myllykangas L., Chiò A., Shatunov A., Boeve B.F., Boxer A.L., DeJesus-Hernandez M., Mackenzie I.R., Waite A., Williams N., Morris H.R., Simón-Sánchez J., van Swieten J.C., Heutink P., Restagno G., Mora G., Morrison K.E., Shaw P.J., Rollinson P.S., Al-Chalabi A., Rademakers R., Pickering-Brown S., Orrell R.W., Nalls M.A., Hardy J. Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol. Aging 2012, 33:209.e3-209.e8.
37. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N.Engl. J. Med. 2013, 369:233-244. Multiple-System Atrophy Research Collaboration.
38. Neumann M. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences. Rev. Neurol. (Paris) 2013, 169:793-798.
39. Nuytemans K., Bademci G., Kohli M.M., Beecham G.W., Wang L., Young J.I., Nahab F., Martin E.R., Gilbert J.R., Benatar M., Haines J.L., Scott W.K., Züchner S., Pericak-Vance M.A., Vance J.M. C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease. Ann. Hum. Genet. 2013, 77:351-363.
40. Nuytemans K., Inchausti V., Beecham G.W., Wang L., Dickson D.W., Trojanowski J.Q., Lee V.M.-Y., Mash D.C., Frosch M.P., Foroud T.M., Honig L.S., Montine T.J., Dawson T.M., Martin E.R., Scott W.K., Vance J.M. Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Mov. Disord. 2014, 29:827-830.
41. Rademakers R. C9orf72 repeat expansions in patients with ALS and FTD. Lancet Neurol. 2012, 11:297-298.
42. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.-M., Kaivorinne A.-L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chiò A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. Ahexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
43. Ross O.A., Vilariño-Güell C., Wszolek Z.K., Farrer M.J., Dickson D.W. Reply to: SNCA variants are associated with increased risk of multiple system atrophy. Ann. Neurol. 2010, 67:414-415.
44. Scholz S.W., Houlden H., Schulte C., Sharma M., Li A., Berg D., Melchers A., Paudel R., Gibbs J.R., Simon-Sanchez J., Paisan-Ruiz C., Bras J., Ding J., Chen H., Traynor B.J., Arepalli S., Zonozi R.R., Revesz T., Holton J., Wood N., Lees A., Oertel W., Wüllner U., Goldwurm S., Pellecchia M.T., Illig T., Riess O., Fernandez H.H., Rodriguez R.L., Okun M.S., Poewe W., Wenning G.K., Hardy J.A., Singleton A.B., Del Sorbo F., Schneider S., Bhatia K.P., Gasser T. SNCA variants are associated with increased risk for multiple system atrophy. Ann. Neurol. 2009, 65:610-614.
45. Schottlaender L.V., Houlden H. Mutant COQ2 in multiple-system atrophy. N.Engl. J. Med. 2014, 371:81. Multiple-System Atrophy (MSA) Brain Bank Collaboration.
46. Segarane B., Li A., Paudel R., Scholz S., Neumann J., Lees A., Revesz T., Hardy J., Mathias C.J., Wood N.W., Holton J., Houlden H. Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 2009, 72:1185-1186.
47. Sharma M., Wenning G., Krüger R. Mutant COQ2 in multiple-system atrophy. N.Engl. J. Med. 2014, 371:80-81. European Multiple-System Atrophy Study Group (EMSA-SG).
48. Snowden J.S., Rollinson S., Lafon C., Harris J., Thompson J., Richardson A.M., Jones M., Gerhard A., Neary D., Mann D.M.A., Pickering-Brown S. Psychosis, C9ORF72 and dementia with Lewy bodies. J.Neurol. Neurosurg. Psychiatry 2012, 83:1031-1032.
49. Ticozzi N., Tiloca C., Calini D., Gagliardi S., Altieri A., Colombrita C., Cereda C., Ratti A., Pezzoli G., Borroni B., Goldwurm S., Padovani A., Silani V. C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. Neurobiol. Aging 2014, 35:936.e13-936.e17.
50. Van Blitterswijk M., Baker M.C., DeJesus-Hernandez M., Ghidoni R., Benussi L., Finger E., Hsiung G.-Y.R., Kelley B.J., Murray M.E., Rutherford N.J., Brown P.E., Ravenscroft T., Mullen B., Ash P.E.A., Bieniek K.F., Hatanpaa K.J., Karydas A., Wood E.M., Coppola G., Bigio E.H., Lippa C., Strong M.J., Beach T.G., Knopman D.S., Huey E.D., Mesulam M., Bird T., White C.L., Kertesz A., Geschwind D.H., Van Deerlin V.M., Petersen R.C., Binetti G., Miller B.L., Petrucelli L., Wszolek Z.K., Boylan K.B., Graff-Radford N.R., Mackenzie I.R., Boeve B.F., Dickson D.W., Rademakers R. C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology 2013, 81:1332-1341.
51. Williams D.R., Lees A.J. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009, 8:270-279.
52. Xi Z., Zinman L., Grinberg Y., Moreno D., Sato C., Bilbao J.M., Ghani M., Hernández I., Ruiz A., Boada M., Morón F.J., Lang A.E., Marras C., Bruni A., Colao R., Maletta R.G., Puccio G., Rainero I., Pinessi L., Galimberti D., Morrison K.E., Moorby C., Stockton J.D., Masellis M., Black S.E., Hazrati L.-N., Liang Y., van Haersma de With J., Fornazzari L., Villagra R., Rojas-Garcia R., Clarimón J., Mayeux R., Robertson J., St George-Hyslop P., Rogaeva E. Investigation of c9orf72 in 4 neurodegenerative disorders. Arch. Neurol. 2012, 69:1583-1590.